Scott Loughhead

1.5k total citations
23 papers, 1.1k citations indexed

About

Scott Loughhead is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Scott Loughhead has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Scott Loughhead's work include Immunotherapy and Immune Responses (14 papers), CAR-T cell therapy research (11 papers) and Immune Cell Function and Interaction (5 papers). Scott Loughhead is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), CAR-T cell therapy research (11 papers) and Immune Cell Function and Interaction (5 papers). Scott Loughhead collaborates with scholars based in United States, Switzerland and Canada. Scott Loughhead's co-authors include Ulrich H. von Andrian, Carmen Gerlach, David Álvarez, Rohit Garg, E. Ashley Moseman, Anthonie J. Zwijnenburg, Juan Carlos de la Torre, David Zemmour, Christophe Benoıst and Diane Mathis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Scott Loughhead

22 papers receiving 1.1k citations

Peers

Scott Loughhead
Paulus Mrass United States
Samantha B. Larsen United States
Tianyang Mao United States
Weiwei Wu China
Marleen Ansems Netherlands
Marie King Ireland
Paulus Mrass United States
Scott Loughhead
Citations per year, relative to Scott Loughhead Scott Loughhead (= 1×) peers Paulus Mrass

Countries citing papers authored by Scott Loughhead

Since Specialization
Citations

This map shows the geographic impact of Scott Loughhead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Loughhead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Loughhead more than expected).

Fields of papers citing papers by Scott Loughhead

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Loughhead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Loughhead. The network helps show where Scott Loughhead may publish in the future.

Co-authorship network of co-authors of Scott Loughhead

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Loughhead. A scholar is included among the top collaborators of Scott Loughhead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Loughhead. Scott Loughhead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weaver, Alice N., Wade T. Iams, Jong Chul Park, et al.. (2024). Final outcomes analysis of the cell product SQZ‐PBMC‐HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltration. Molecular Carcinogenesis. 63(8). 1421–1428. 2 indexed citations
2.
Ouellet, Éric, Ulrike Lambertz, Jessie Z. Yu, et al.. (2024). Highly efficient non-viral delivery of macromolecules to unactivated human T cells using microfluidic transfection. The Journal of Immunology. 212(1_Supplement). 0263_5530–0263_5530.
3.
Bernstein, Howard, Scott Loughhead, Ricardo Zwirtes, et al.. (2022). Cell Squeeze: driving more effective CD8 T-cell activation through cytosolic antigen delivery. Immuno-Oncology Technology. 16. 100091–100091. 11 indexed citations
5.
Jimeno, Antonio, Joaquina Baranda, Monica Mita, et al.. (2021). Initial results of a first-in-human, dose escalation study of a cell-based vaccine in HLA A*02+ patients (pts) with recurrent, locally advanced or metastatic HPV16+ solid tumors: SQZ-PBMC-HPV-101.. Journal of Clinical Oncology. 39(15_suppl). 2536–2536. 6 indexed citations
6.
Ozay, Emrah Ilker, P. Rod Dunbar, Michael F. Maloney, et al.. (2021). Abstract 1525: Enhancing potency of antigen presenting cells via signal 2/3 mRNA engineering through Cell Squeeze® technology. Cancer Research. 81(13_Supplement). 1525–1525. 1 indexed citations
7.
Smith, Carolyne K., Lindsay S. Moore, Emrah Ilker Ozay, et al.. (2021). 156 RBC-derived, activating antigen carriers (SQZ AACs) prime potent T cell responses and drive tumor regression in vivo. SHILAP Revista de lepidopterología. A166–A166. 1 indexed citations
8.
Yarar, Defne, Carolyne K. Smith, Scott Loughhead, et al.. (2021). Abstract 1524: Peripheral blood mononuclear cells engineered via microfluidic Cell Squeeze® technology to generate APCs that drive mutant-KRas-specific CD8+ T cell responses. Cancer Research. 81(13_Supplement). 1524–1524. 1 indexed citations
9.
Maloney, Michael F., Scott Loughhead, Carolyne K. Smith, et al.. (2020). 169 Microfluidics cell squeezing enables human PBMCs as drivers of antigen-specific CD8 T responses across broad range of antigens for diverse clinical applications. SHILAP Revista de lepidopterología. A102.1–A102. 2 indexed citations
10.
Ozay, Emrah Ilker, Matthew G. Booty, David Soto, et al.. (2020). 170 Microfluidics cell squeezing enables potent cellular vaccines in murine models through direct cytosolic loading and direct CD8 T cell priming. SHILAP Revista de lepidopterología. A102.2–A102. 2 indexed citations
11.
Booty, Matthew G., Christine Trumpfheller, Valeria Nicolini, et al.. (2020). 141 PBMC-based cancer vaccines generated with microfluidics squeezing demonstrate synergistic and durable tumor reduction in combination with PD1 checkpoint and FAP targeted IL-2 variants. Regular and Young Investigator Award Abstracts. A86.1–A86. 3 indexed citations
12.
Booty, Matthew G., et al.. (2019). Abstract 3187: Engineering a new generation of cell therapies for solid tumor oncology using the SQZ platform. Cancer Research. 79(13_Supplement). 3187–3187. 1 indexed citations
13.
DiTommaso, Tia, Luke Cassereau, Scott Loughhead, et al.. (2018). Cell engineering with microfluidic squeezing preserves functionality of primary immune cells in vivo. Proceedings of the National Academy of Sciences. 115(46). E10907–E10914. 151 indexed citations
14.
Loughhead, Scott, et al.. (2018). SQZing cells to rapidly generate antigen presenting cells (APC) for solid tumor immune therapies with efficient, scalable manufacturing. Annals of Oncology. 29. x13–x13. 1 indexed citations
15.
Zemmour, David, Alvin Pratama, Scott Loughhead, Diane Mathis, & Christophe Benoıst. (2017). Flicr , a long noncoding RNA, modulates Foxp3 expression and autoimmunity. Proceedings of the National Academy of Sciences. 114(17). E3472–E3480. 131 indexed citations
16.
Prüß, Harald, Andrea Tedeschi, Aude Thiriot, et al.. (2017). Spinal cord injury-induced immunodeficiency is mediated by a sympathetic-neuroendocrine adrenal reflex. Nature Neuroscience. 20(11). 1549–1559. 116 indexed citations
17.
Azzi, Jamil, Qian Yin, Mayuko Uehara, et al.. (2016). Targeted Delivery of Immunomodulators to Lymph Nodes. Cell Reports. 15(6). 1202–1213. 86 indexed citations
18.
Gerlach, Carmen, E. Ashley Moseman, Scott Loughhead, et al.. (2016). The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis. Immunity. 45(6). 1270–1284. 367 indexed citations
19.
Henrickson, Sarah E., Mario Perro, Scott Loughhead, et al.. (2013). Antigen Availability Determines CD8+ T Cell-Dendritic Cell Interaction Kinetics and Memory Fate Decisions. Immunity. 39(3). 496–507. 115 indexed citations
20.
Redeker, Anke, Suzanne P. M. Welten, Bjoern Peters, et al.. (2012). Polyfunctional CD4+ T Cell Responses to Immunodominant Epitopes Correlate with Disease Activity of Virulent Salmonella. PLoS ONE. 7(8). e43481–e43481. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026